Treatment with the novel Akt inhibitor AZD5363 following radiotherapy improves tumour control in mouse models of head and neck cancer

Research output: Contribution to journal › Meeting Abstract › peer-review

Research Beacons, Institutes and Platforms

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{5691d74617ec4afeb06db10e5823368e,

title = "Treatment with the novel Akt inhibitor AZD5363 following radiotherapy improves tumour control in mouse models of head and neck cancer",

author = "Emma Searle and Brian Telfer and Duncan Forster and Davies, {Barry R} and Ian Stratford and Timothy Illidge and Kaye Williams",

year = "2016",

doi = "10.1016/S0959-8049(16)61573-3",

language = "English",

volume = "61",

pages = "S162",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier BV",

number = "Supplement 1",

}

TY - JOUR

T1 - Treatment with the novel Akt inhibitor AZD5363 following radiotherapy improves tumour control in mouse models of head and neck cancer

AU - Searle, Emma

AU - Telfer, Brian

AU - Forster, Duncan

AU - Davies, Barry R

AU - Stratford, Ian

AU - Illidge, Timothy

AU - Williams, Kaye

PY - 2016

Y1 - 2016

U2 - 10.1016/S0959-8049(16)61573-3

DO - 10.1016/S0959-8049(16)61573-3

M3 - Meeting Abstract

SN - 0959-8049

VL - 61

SP - S162

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - Supplement 1

ER -